Regulation And Legal
Sun Pharma Clarifies Assam Plant Quality Issue Report
Sun Pharma responds to stock exchanges regarding news report about production halt at Assam facility due to quality lapses.
Clarifies that the reported events occurred in August 2026 and were assessed
